Pregnant Women Clinical Trial
Official title:
Xiamen Registry of Pregnant Women and Offspring (REPRESENT): A Population-based, Long-term Follow-up Database Linking Four Major Healthcare Data Platforms
Verified date | January 2020 |
Source | West China Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
To improve the health of women and children under the background of Healthy China 2030, the
investigators developed REPRESENT by establishing a pregnancy registry in Xiamen, a
sub-provincial city of over four million residents in east China, based on the Maternal and
Child Health Management Platform, and then linking to three other platforms, i.e. Residents
Healthcare Management Platform, Primary Healthcare Management Platform, and Electronic
Healthcare Records (EHR) Platform, which had been developed since 2006. The registry
documented information and events about pregnant women from registration at their first
trimester to postpartum, and includes the childhood follow up records. The registry not only
enables longitudinal follow up of pregnant women and their offspring, but also expands the
scope of database from pre-pregnancy exposures to long-term outcomes by data linkage.
During the past 11 years (January 2008 to March 2019), the REPRESENT has accumulated data
concerning more than 700 thousands pregnancies. The data volume is substantial with over 800
variables being documented, and most variables are designed as structured fields. The disease
categories and codes are standardized according to the International Classification of
Diseases 10th Revision (ICD-10). The whole process of data access, data extraction, data
processing and data analysis was conducted through an internal-only accessible server at
Xiamen Health and Medical Big Data Center. All investigators cannot access sensitive
information, are required to sign data confidentiality agreement and should obtain approval
by the Xiamen Health and Medical Big Data Center and the Chinese Evidence-based Medicine
Center.
Status | Active, not recruiting |
Enrollment | 761194 |
Est. completion date | December 2023 |
Est. primary completion date | March 2019 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 14 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Pregnant women who registered at the Maternal and Child Health Management Platform in Xiamen. Exclusion Criteria: - None. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
West China Hospital | Xiamen Health and Medical Big Data Center, Xiamen Health Commission |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Incidence of pre-eclampsia | Maternal systolic blood pressure = 140 mmHg and (or) diastolic pressure = 90 mmHg, accompanied by any one of the following: urinary protein = 0.3g/24 h, or the ratio of urinary protein and creatinine = 0.3, or random urine protein = (+) if quantitative urine protein is not available; no proteinuria but with any damages of heart, lung, liver, kidney and other important organs, or with abnormal changes of blood system, digestive system and nervous system, or placenta fetus involvement, etc. | Up to 42 weeks | |
Primary | Incidence of eclampsia | Tonic-clonic seizures (convulsions) in preeclampsia patients, including convulsions and coma, not due to pre-existing or organic brain disorders. | Up to 42 weeks | |
Primary | Incidence of gestational diabetes | By oral glucose tolerance test between 24 and 28 gestational weeks (fasting glucose =5.1 mmol/L, 1-h glucose =10.0 mmol/L, 2-h glucose =8.5 mmol/L; one abnormal result sufficient). | Up to 32 weeks | |
Primary | Incidence of ruptured uterus | Rupture of maternal uterus confirmed by laparotomy. | Up to 42 weeks | |
Primary | Incidence of postpartum hemorrhage | Postpartum bleeding volume =500 mL. | Within 24h after delivery | |
Primary | Incidence of maternal death | Maternal death | Up to 52 weeks | |
Primary | Incidence of birth defects | Birth defects such as anencephaly, spina bifida, encephalocele, hydrocephalus, cleft palate, cleft lip, microtia, esophageal atresia or stenosis, anorectal, hypospadias, ectropion of bladder, talipes equinovarus, polydactylism, ankylodactylia, congenital diaphragmatic hernia, umbilical cord prolapse, gastroschisis, conjoined twins, down syndrome, congenital heart disease, or other birth defects. | Up to 7 years | |
Primary | Incidence of preterm birth | Delivery before 37th gestational weeks. | Up to 37 weeks | |
Primary | Incidence of neonatal birth weight | Neonatal birth weight measured after birth. | Up to 42 weeks | |
Primary | Incidence of neonatal death | Neonatal death | Within 28 days after delivery | |
Primary | Incidence of stillbirth | Fetus death at or after 20-28 weeks of gestation. | Up to 42 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03955263 -
Malaria In Pregnancy in Central India
|
||
Not yet recruiting |
NCT04457947 -
Exploring Aromatherapy Intervention in Acute Care
|
||
Active, not recruiting |
NCT01397318 -
Effects of Modified TaiChi Exercise on Maternal Stress, Fatigue, Sleep Quality, Biomarkers, and Infant Gestational Age and Birthweight
|
N/A | |
Completed |
NCT00639145 -
Elizabeth Glaser Pediatric AIDS Foundation Maternal Events and Pregnancy Outcomes (MEP Project)A Multi-site Protocol
|
||
Not yet recruiting |
NCT00931099 -
Fetal Outcome of Sleep Disordered Breathing During Pregnancy
|
N/A | |
Recruiting |
NCT00751569 -
microRNA Profile in Umbilical Cord Blood NK Cells
|
N/A | |
Completed |
NCT06111716 -
Mindfulness in Childbirth Preparation Education Process
|
N/A | |
Completed |
NCT05729191 -
Evaluation of the Acceptance of the Anti-COVID-19 Vaccine Offer Among Pregnant Women
|
||
Completed |
NCT01687634 -
Home Visiting for Low Income, Pregnant Women
|
N/A | |
Recruiting |
NCT05446571 -
Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Versus Valaciclovir
|
Phase 3 | |
Not yet recruiting |
NCT03651934 -
Verification of Correlation Between Genetic Testing of Nutritional Metabolism and Clinical Biochemical Indicators
|
N/A | |
Active, not recruiting |
NCT06422130 -
Ningbo Maternity-Child Linked Database Study
|
||
Completed |
NCT02904473 -
Goals for Reaching Optimum Wellness (GROWell)
|
N/A | |
Completed |
NCT03538106 -
Factors Associated With Cesarean Delivery in Women With Type 1 Diabetes
|
||
Recruiting |
NCT01246765 -
National Pregnancy Registry for Psychiatric Medications
|
||
Completed |
NCT00553228 -
Pertussis Maternal Immunization Study
|
Phase 2/Phase 3 | |
Recruiting |
NCT05916534 -
We Care About Brooklyn - A Digital Behavioral Intervention to Optimize Engagement in Maternal Healthcare
|
N/A | |
Completed |
NCT04264910 -
CALM Pregnancy: Feasibility of Calm for Pregnant Women
|
N/A | |
Completed |
NCT04494581 -
GriCoVax Study in 4 Maternity Wards in the Ile-de-France Region
|
||
Recruiting |
NCT05349279 -
Qatar PREgnancy Covid-19 OUtcome Study
|